Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BAY-1797

🥰Excellent
Catalog No. T10466Cas No. 2055602-83-8

BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against human P2X4) with anti-nociceptive and anti-inflammatory effects. BAY-1797 displays no or very weak activity on the other P2X ion channels.

BAY-1797

BAY-1797

🥰Excellent
Purity: 98.01%
Catalog No. T10466Cas No. 2055602-83-8
BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against human P2X4) with anti-nociceptive and anti-inflammatory effects. BAY-1797 displays no or very weak activity on the other P2X ion channels.
Pack SizePriceAvailabilityQuantity
1 mg$34In Stock
5 mg$77In Stock
10 mg$129In Stock
25 mg$272In Stock
50 mg$463In Stock
100 mg$737In Stock
1 mL x 10 mM (in DMSO)$85In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "BAY-1797"

Select Batch
Purity:98.01%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against human P2X4) with anti-nociceptive and anti-inflammatory effects. BAY-1797 displays no or very weak activity on the other P2X ion channels.
Targets&IC50
P2X3 (human):8.3 μM , P2X1 (human):>50 μM , P2X23 (human):>30 μM , P2X4 (human):211 nM , P2X7 (human):10.6 μM
In vitro
BAY-1797 inhibits human, mouse, and rat P2X4 in 1321N1 cells (IC50s: 108 nM, 112 nM, and 233 nM). BAY-1797 exerts no measurable activity on hERG and carbonic anhydrase II (both IC50>10 μM). BAY-1797 (10 μM) is also tested against a panel of off-targets, including GPCRs, ion channels, kinases, and transporters. Inhibitory activity against the dopamine transporter (IC50: 2.17 μM) was revealed as the only hit.
In vivo
BAY-1797 (12.5-50 mg/kg; p.o.) significantly induces PGE2 levels in the inflamed paw in the mouse Complete Freund’s Adjuvant (CFA) inflammatory pain model. At 50 mg/kg daily, BAY-1797 significantly reduces ipsilateral paw load 24 and 48 hours post-CFA injection. Pharmacokinetic parameters include AUCnorm of 1.06 kg h/L, Vss of 3.67 L/kg, and t1/2 of 2.64 hours.
Chemical Properties
Molecular Weight416.88
FormulaC20H17ClN2O4S
Cas No.2055602-83-8
SmilesNS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1
Relative Density.1.414 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 250 mg/mL (599.69 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3988 mL11.9939 mL23.9877 mL119.9386 mL
5 mM0.4798 mL2.3988 mL4.7975 mL23.9877 mL
10 mM0.2399 mL1.1994 mL2.3988 mL11.9939 mL
20 mM0.1199 mL0.5997 mL1.1994 mL5.9969 mL
50 mM0.0480 mL0.2399 mL0.4798 mL2.3988 mL
100 mM0.0240 mL0.1199 mL0.2399 mL1.1994 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BAY-1797 | purchase BAY-1797 | BAY-1797 cost | order BAY-1797 | BAY-1797 chemical structure | BAY-1797 in vivo | BAY-1797 in vitro | BAY-1797 formula | BAY-1797 molecular weight